Literature DB >> 8985326

Induction of an exceptionally high-level, nontranslated, Epstein-Barr virus-encoded polyadenylated transcript in the Burkitt's lymphoma line Daudi.

Y Gao1, P R Smith, L Karran, Q L Lu, B E Griffin.   

Abstract

An Epstein-Barr virus transcript (designated D-HIT [Daudi high-level-inducible transcript]), constitutively expressed at low levels in the Burkitt's lymphoma (BL)-derived cell line Daudi, can be induced with tetradecanoylphorbol acetate or n-butyrate or, in combination, to about 1% of the levels of high-molecular-weight RNAs in cells. The transcript can also be induced in some other EBV-positive BL-derived cells but to a much lesser extent, particularly in lines that can give rise to productive infection. D-HIT is viral in origin and is composed largely of repetitive sequence. It is polyadenylated but mainly nuclear in location and is highly structured, sensitive only to double-strand-specific RNase. It is endogenously expressed in interferon-sensitive Daudi strains but not in an insensitive strain, Daudi 100K. D-HIT contains a part of a viral open reading frame (designated LF3, and deleted in the prototype B95-8 strain), using an internal polyadenylation (AAUAAA) sequence as a signal to specify processing of its 3' end. In Daudi cells, the promoter contains a putative hinge structure, as found in some interferon-inducible genes and c-myc. Since D-HIT lies adjacent to, probably even encompassing, one of the two viral lytic origins (D(R)) of replication, it may have a role in the regulation of DNA replication. Alternatively, or in addition via its double-stranded structure, D-HIT may play a regulatory role in interferon pathways. Its promoter could be of value for studying expression in constructions containing heterologous genes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985326      PMCID: PMC191027     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Identification of the gene product encoded by the PstI repeats (IR4) of the Epstein-Barr virus genome.

Authors:  C M Nuebling; N Mueller-Lantzsch
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

2.  Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region.

Authors:  B D Parker; A Bankier; S Satchwell; B Barrell; P J Farrell
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

3.  Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.

Authors:  W Hammerschmidt; B Sugden
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

4.  Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.

Authors:  J Countryman; H Jenson; R Seibl; H Wolf; G Miller
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

5.  DNA H form requires a homopurine-homopyrimidine mirror repeat.

Authors:  S M Mirkin; V I Lyamichev; K N Drushlyak; V N Dobrynin; S A Filippov; M D Frank-Kamenetskii
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

6.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer.

Authors:  M A Frohman; M K Dush; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Properties of two 5'-coterminal RNAs transcribed part way and across the S component origin of DNA synthesis of the herpes simplex virus 1 genome.

Authors:  J H Voss; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.

Authors:  W Hammerschmidt; B Sugden
Journal:  Nature       Date:  1989-08-03       Impact factor: 49.962

9.  An Epstein-Barr virus immortalization associated gene segment interferes specifically with the IFN-induced anti-proliferative response in human B-lymphoid cell lines.

Authors:  P Aman; A von Gabain
Journal:  EMBO J       Date:  1990-01       Impact factor: 11.598

10.  EBV gene expression in an NPC-related tumour.

Authors:  M M Hitt; M J Allday; T Hara; L Karran; M D Jones; P Busson; T Tursz; I Ernberg; B E Griffin
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  9 in total

1.  Sensitivity of an epstein-barr virus-positive tumor line, Daudi, to alpha interferon correlates with expression of a GC-rich viral transcript.

Authors:  Y Gao; S a Xue; B E Griffin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Expression of two related viral early genes in Epstein-Barr virus-associated tumors.

Authors:  S A Xue; Q L Lu; R Poulsom; L Karran; M D Jones; B E Griffin
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Genetic diversity: frameshift mechanisms alter coding of a gene (Epstein-Barr virus LF3 gene) that contains multiple 102-base-pair direct sequence repeats.

Authors:  Shao-An Xue; M D Jones; Qi-Long Lu; J M Middeldorp; Beverly E Griffin
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

4.  Initiation of Epstein-Barr virus lytic replication requires transcription and the formation of a stable RNA-DNA hybrid molecule at OriLyt.

Authors:  Andrew J Rennekamp; Paul M Lieberman
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

5.  Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing.

Authors:  Lijuan Hu; Zhirui Lin; Yanheng Wu; Juqin Dong; Bo Zhao; Yanbing Cheng; Peiyu Huang; Lihua Xu; Tianliang Xia; Dan Xiong; Hongbo Wang; Manzhi Li; Ling Guo; Elliott Kieff; Yixin Zeng; Qian Zhong; Musheng Zeng
Journal:  Front Med       Date:  2016-03-11       Impact factor: 4.592

6.  Quantitative and qualitative RNA-Seq-based evaluation of Epstein-Barr virus transcription in type I latency Burkitt's lymphoma cells.

Authors:  Zhen Lin; Guorong Xu; Nan Deng; Christopher Taylor; Dongxiao Zhu; Erik K Flemington
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

7.  A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.

Authors:  Vladimir Majerciak; Wenjing Yang; Jing Zheng; Jun Zhu; Zhi-Ming Zheng
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

8.  Translational profiling of B cells infected with the Epstein-Barr virus reveals 5' leader ribosome recruitment through upstream open reading frames.

Authors:  Maja Bencun; Olaf Klinke; Agnes Hotz-Wagenblatt; Severina Klaus; Ming-Han Tsai; Remy Poirey; Henri-Jacques Delecluse
Journal:  Nucleic Acids Res       Date:  2018-04-06       Impact factor: 16.971

9.  Complexities associated with expression of Epstein-Barr virus (EBV) lytic origins of DNA replication.

Authors:  Shao-An Xue; Beverly E Griffin
Journal:  Nucleic Acids Res       Date:  2007-05-03       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.